Organization Overview
Alternative names
ammonia n-13 (2013)
choline c11 (choline c-11) (2012)
fenofibrate (fenoglide) (2009)
fludeoxyglucose f-18 (2014)
sodium fluoride-18f (2013)
tramadol (Ultram) (2020)
abatacept (orencia) (4 trials)
acetaminophen (tylenol) (6 trials)
acetylsalicylic acid (aspirin) (8 trials)
adalimumab (humira) (3 trials)
albuterol (proventil) (3 trials)
amlodipine (norvasc) (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (4 trials)
apremilast (otezla) (2 trials)
atomoxetine (strattera) (3 trials)
atorvastatin (lipitor) (5 trials)
azathioprine (imuran) (3 trials)
betamethasone (celestone) (3 trials)
bromocriptine (parlodel) (1 trial)
budesonide (rhinocort) (2 trials)
bupivacaine (Exparel) (3 trials)
cabergoline (dostinex) (1 trial)
calcitriol (rocaltrol) (1 trial)
canakinumab (ilaris) (1 trial)
celecoxib (celebrex) (8 trials)
chlorhexidine (hibitane) (4 trials)
deferiprone (ferriprox) (5 trials)
deferoxamine (desferal) (4 trials)
duloxetine (Cymbalta) (1 trial)
escitalopram (lexapro) (8 trials)
ethinyl estradiol (Estinyl) (4 trials)
fesoterodine (toviaz) (4 trials)
fluocinolone acetonide (synalar) (1 trial)
fluorometholone (fml) (2 trials)
fluoxetine (prozac) (6 trials)
fluticasone (cutivate) (2 trials)
grazoprevir (zepatier) (4 trials)
icosapent ethyl (vascepa) (8 trials)
inactivated influenza vaccine (6 trials)
indomethacin (indocin) (1 trial)
ipratropium (atrovent) (1 trial)
ketorolac (acuvail) (2 trials)
ledipasvir (Harvoni) (1 trial)
levalbuterol (xopenex) (1 trial)
lisdexamfetamine (vyvanse) (5 trials)
lithium (lithonate) (4 trials)
magnesium sulfate (Tis-U-Sol) (2 trials)
methylphenidate (ritalin) (1 trial)
methylprednisolone (medrol) (3 trials)
metoprolol (lopressor) (1 trial)
miconazole (monistat) (1 trial)
misoprostol (cytotec) (3 trials)
mycophenolate (myfortic) (7 trials)
naltrexone (revia) (41 trials)
naproxen (naprosyn) (3 trials)
nicotine (nicorette) (13 trials)
oritavancin (orbactiv) (1 trial)
oxycodone (oxycontin) (3 trials)
oxytocin (syntocinon) (6 trials)
paricalcitol (zemplar) (5 trials)
phentermine (wyamine) (1 trial)
phentolamine mesylate (regitine) (2 trials)
pibrentasvir (Mavyret) (1 trial)
pimecrolimus (elidel) (3 trials)
pioglitazone (actos) (2 trials)
progesterone (progestasert) (4 trials)
remifentanil (ultiva) (1 trial)
rivastigmine (exelon) (1 trial)
ropivacaine (naropin) (5 trials)
rosuvastatin (crestor) (2 trials)
secukinumab (cosentyx) (3 trials)
sertraline (zoloft) (12 trials)
simvastatin (zocor) (5 trials)
sirolimus (rapamune) (15 trials)
sitagliptin (januvia) (8 trials)
sofosbuvir (sovaldi) (3 trials)
spironolactone (aldactone) (4 trials)
sulfur hexafluoride lipid-type a microspheres (Lumason) (5 trials)
tacrolimus (prograf) (4 trials)
tofacitinib (xeljanz) (1 trial)
topiramate (topamax) (7 trials)
upadacitinib (Rinvoq) (1 trial)
ustekinumab (stelara) (1 trial)
varenicline (chantix) (18 trials)
vedolizumab (entyvio) (1 trial)
venlafaxine (effexor) (7 trials)
vigabatrin (sabril) (2 trials)
abobotulinumtoxinA (Dysport) (1 trial)
acetazolamide (diamox) (2 trials)
acetylcysteine (mucomyst) (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (2 trials)
allogeneic pancreatic islet cells (2 trials)
amiodarone (cordarone) (2 trials)
amitriptyline (elavil) (1 trial)
asparaginase (elspar) (3 trials)
azithromycin (zithromax) (2 trials)
basiliximab (simulect) (2 trials)
bevacizumab (avastin) (9 trials)
bicalutamide (casodex) (1 trial)
carboplatin (paraplatin) (8 trials)
cetuximab (erbitux) (3 trials)
cisplatin (platinol) (19 trials)
citalopram (celexa) (2 trials)
clevidipine (cleviprex) (2 trials)
clindamycin (cleocin) (1 trial)
cyclophosphamide (cytoxan) (25 trials)
cyclosporine (sandimmune) (5 trials)
cytarabine (cytosar-u) (9 trials)
dalfampridine (ampyra) (1 trial)
daunorubicin (cerubidine) (3 trials)
dofetilide (tikosyn) (2 trials)
donepezil (aricept) (2 trials)
doxorubicin (Doxil) (8 trials)
dronedarone (multaq) (1 trial)
drospirenone (Yasmin) (1 trial)
enalapril (vasotec) (3 trials)
enoxaparin (lovenox) (1 trial)
etanercept (enbrel) (2 trials)
ethosuximide (zarontin) (1 trial)
etoposide (vepesid) (16 trials)
fish oil (Omegavan) (3 trials)
flecainide (tambocor) (2 trials)
fludeoxyglucose f-18 (18 trials)
fluorouracil (efudex) (10 trials)
gemcitabine (gemzar) (18 trials)
gemtuzumab ozogamicin (mylotarg) (2 trials)
hydroxyurea (hydrea) (4 trials)
idursulfase (elaprase) (1 trial)
insulin human (humulin) (3 trials)
interferon alpha-2b (Intron-A) (5 trials)
irinotecan (Camptosar) (7 trials)
isotretinoin (accutane) (2 trials)
isradipine (dynacirc) (1 trial)
lamotrigine (lamictal) (1 trial)
leuprolide (lupron) (2 trials)
levamisole (ergamisol) (1 trial)
lidocaine (xylocaine) (3 trials)
lomitapide (juxtapid) (3 trials)
loperamide (imodium) (1 trial)
medroxyprogesterone (provera) (2 trials)
metformin (glucophage) (3 trials)
methadone (methadose) (3 trials)
mifepristone (mifeprex) (3 trials)
mitomycin (mutamycin) (3 trials)
mitoxantrone (novantrone) (4 trials)
nilutamide (nilandron) (1 trial)
nitric oxide (inomax) (2 trials)
omega-3 fatty acids (omacor) (2 trials)
onabotulinumtoxinA (Botox) (1 trial)
oxaliplatin (eloxatin) (8 trials)
propafenone (rythmol) (2 trials)
propranolol (inderal) (5 trials)
quetiapine (seroquel) (2 trials)
(r)-3-hydroxybutyl (r)-3-hydroxybutyrate (2 trials)
ramelteon (rozerem) (2 trials)
ranibizumab (lucentis) (1 trial)
rimabotulinumtoxinB (Myobloc) (2 trials)
rituximab (rituxan) (7 trials)
sacubitril (Entresto) (1 trial)
sargramostim (leukine) (11 trials)
sildenafil (viagra) (6 trials)
sorafenib (nexavar) (9 trials)
sulfamethoxazole (gantanol) (2 trials)
testosterone (delatestryl) (2 trials)
thyrotropin releasing hormone (3 trials)
tranexamic acid (cyklokapron) (1 trial)
valproic acid (depakene) (1 trial)
vincristine (oncovin) (7 trials)
aav directed hldlr gene therapy (1 trial)
abemaciclib (verzenio) (3 trials)
acamprosate (campral) (2 trials)
acetic acid (vosol) (3 trials)
acetohydroxamic acid (1 trial)
adeno-associated viral with human factor ix (1 trial)
adenovirus-specific t-cells (1 trial)
aldesleukin (proleukin) (3 trials)
alemtuzumab (campath) (2 trials)
allogeneic cord blood (1 trial)
allogeneic plx-pad cells (1 trial)
allopurinol (zyloprim) (1 trial)
amantadine (symmetrel) (2 trials)
anastrozole (arimidex) (2 trials)
armodafinil (nuvigil) (2 trials)
atazanavir (reyataz) (2 trials)
atezolizumab (tecentriq) (1 trial)
autologous bone marrow (2 trials)
autologous mononuclear stem cell (2 trials)
autologous oxidized tumor cell lysate vaccine (2 trials)
autologous umbilical cord blood (1 trial)
avelumab (bavencio) (2 trials)
baclofen (lioresal) (3 trials)
baricitinib (olumiant) (1 trial)
belantamab mafodotin (1 trial)
belimumab (benlysta) (1 trial)
beta carotene (solatene) (1 trial)
bexarotene (targretin) (2 trials)
binimetinib (mektovi) (1 trial)
bk cytotoxic t lymphocytes (1 trial)
bortezomib (velcade) (2 trials)
brentuximab vedotin (adcetris) (1 trial)
bupropion (wellbutrin) (3 trials)
cabozantinib (cometriq) (1 trial)
capecitabine (xeloda) (3 trials)
carbamazepine (tegretol) (1 trial)
carglumic acid (carbaglu) (3 trials)
cariprazine (vraylar) (2 trials)
cd3,cd19 depleted hematopoietic stem cells (1 trial)
cd3/cd28 stimulated t cells (3 trials)
cenegermin-bkbj (oxervate) (1 trial)
cephalexin (keflex) (3 trials)
certolizumab pegol (cimzia) (1 trial)
ciprofloxacin (cipro) (4 trials)
clopidogrel (plavix) (1 trial)
cmv-specific t-cells (1 trial)
cobimetinib (cotellic) (1 trial)
colchicine (colbenemid) (1 trial)
ctl019 transduced cells (2 trials)
cytolytic t-lymphocytes (1 trial)
daclizumab (Zenapax) (2 trials)
dapagliflozin (farxiga) (1 trial)
darbepoetin alfa (aranesp) (1 trial)
deferasirox (exjade) (2 trials)
dendritic cell vaccine for high risk ovarian cancer patients (1 trial)
deutetrabenazine (austedo) (1 trial)
dextromethorphan (delsym) (2 trials)
disulfiram (antabuse) (1 trial)
dobutamine (dobutrex) (1 trial)
docetaxel (taxotere) (4 trials)
dronabinol (marinol) (1 trial)
dulaglutide (trulicity) (1 trial)
durvalumab (imfinzi) (2 trials)
duvelisib (copiktra) (1 trial)
eltrombopag (promacta) (1 trial)
empagliflozin (jardiance) (1 trial)
emtricitabine (emtriva) (2 trials)
erwinia asparaginase (Erwinaze) (1 trial)
etirinotecan pegol (Onzeald) (1 trial)
etravirine (intelence) (1 trial)
everolimus (zortress) (8 trials)
exemestane (aromasin) (1 trial)
fenofibrate (fenoglide) (5 trials)
fluconazole (diflucan) (4 trials)
fulvestrant (faslodex) (2 trials)
gabapentin (neurontin) (1 trial)
galantamine (reminyl) (4 trials)
gepirone monohydrochloride (1 trial)
glatiramer acetate (copaxone) (1 trial)
glycerol phenylbutyrate (ravicti) (1 trial)
hemopoietic stem cell (1 trial)
her-2 pulsed dendritic cells (3 trials)
human fecal microbiota (4 trials)
hyaluronidase (human recombinant) (hylenex) (1 trial)
hydralazine (apresoline) (1 trial)
hydroxychloroquine (plaquenil) (21 trials)
in vitro-treated bone marrow (1 trial)
iobenguane sulfate i-131 (3 trials)
ipilimumab (yervoy) (7 trials)
isosorbide (isordil) (2 trials)
ixabepilone (ixempra) (1 trial)
lenalidomide (revlimid) (5 trials)
lenvatinib (lenvima) (1 trial)
levomethadyl acetate (orlaam) (1 trial)
liothyronine (cytomel) (3 trials)
lofexidine (lucemyra) (3 trials)
lovastatin (mevacor) (1 trial)
maraviroc (selzentry) (3 trials)
mecasermin (increlex) (3 trials)
melphalan (alkeran) (4 trials)
mercaptopurine (purinethol) (2 trials)
methylene blue (proveblue) (3 trials)
metoclopramide (reglan) (2 trials)
midostaurin (rydapt) (1 trial)
modafinil (provigil) (3 trials)
motexafin gadolinium (2 trials)
mupirocin (bactroban) (2 trials)
n-(4-hydroxyphenyl)all-trans retinamide (1 trial)
nelfinavir (viracept) (6 trials)
nivolumab (opdivo) (10 trials)
ny-eso-1c259-modified t cells (1 trial)
obinutuzumab (gazyva) (1 trial)
olaparib (lynparza) (3 trials)
oligomeric proanthocyanidins (1 trial)
omalizumab (xolair) (2 trials)
omeprazole (prilosec) (1 trial)
ondansetron (zofran) (1 trial)
oxymetazoline (ocuclear) (1 trial)
pancrelipase (creon) (2 trials)
panitumumab (vectibix) (1 trial)
pantoprazole (protonix) (1 trial)
pasireotide (signifor) (1 trial)
pegaspargase (oncaspar) (1 trial)
pembrolizumab (keytruda) (15 trials)
pemetrexed (alimta) (3 trials)
pentostatin (nipent) (1 trial)
perflutren protein-type a microspheres (Optison) (2 trials)
peripheral blood hematopoietic cell (4 trials)
pneumococcal 13-valent conjugate vaccine (prevnar 13) (3 trials)
pneumococcal 7-valent conjugate vaccine (prevnar) (1 trial)
polyethylene glycol 3350 (colyte) (1 trial)
porfimer (photofrin) (2 trials)
potassium chloride (klor-con) (5 trials)
pravastatin (pravachol) (1 trial)
pregabalin (lyrica) (2 trials)
promethazine hydrochloride (phenergan) (1 trial)
ramucirumab (cyramza) (1 trial)
regorafenib (stivarga) (1 trial)
rucaparib (rubraca) (2 trials)
ruxolitinib (jakafi) (2 trials)
selegiline (zelapar) (1 trial)
sodium phenylbutyrate (buphenyl) (2 trials)
somatropin (protropin) (3 trials)
tamoxifen (nolvadex) (1 trial)
temozolomide (temodar) (8 trials)
tetracaine (pontocaine) (2 trials)
tocilizumab (actemra) (3 trials)
trametinib (mekinist) (2 trials)
trastuzumab (herceptin) (1 trial)
umbilical cord mesenchymal stem cells (1 trial)
ursodeoxycholic acid (2 trials)
vancomycin (Vancocin) (3 trials)
vasopressin (vasostrict) (1 trial)
velpatasvir (Epclusa) (2 trials)
vemurafenib (zelboraf) (2 trials)
vinblastine (velban) (3 trials)
vinorelbine (navelbine) (1 trial)
18f fluorthanatrace (4 trials)
adenoviral-mediated interferon-beta (1 trial)
adenoviral vector-mediated gene transfer of ornithine transcarbamylase (1 trial)
aglatimagene besadenovec (2 trials)
allogeneic lymphocytes (1 trial)
allogeneic stem cells (1 trial)
alpha/6-gag-tcr modified t cells (1 trial)
aluminum hydroxide (Gaviscon) (1 trial)
aminocaproic acid (amicar) (2 trials)
aminolevulinic acid (levulan) (3 trials)
autologous anti-cd 123 car tcr/4-1bb-expressing t-lymphocytes (1 trial)
autologous cd4 t-cells (1 trial)
autologous cd4+ t cells genetically modified with a retroviral vector expressing the mazf endoribonuclease gene (1 trial)
autologous dendritic cells (1 trial)
autologous genetically modified t cells, ny-eso-1c259 t (1 trial)
autologous mesenchymal stem cells (1 trial)
bivalirudin (angiomax) (1 trial)
bk-virus specific ctls (1 trial)
blinatumomab (blincyto) (1 trial)
bowman-birk inhibitor (2 trials)
car2 anti-cd38 a2 car-t cells (1 trial)
carfilzomib (kyprolis) (1 trial)
cart-psma-tgfbetardn cells (1 trial)
cd4 car+ccr5 zfn t-cells (1 trial)
clavulanate (Augmentin) (3 trials)
cocaine (Erythroxyline) (1 trial)
COVID-19 convalescent plasma (2 trials)
dendritic cell-mart-1 peptide vaccine (1 trial)
dimethyl sulfoxide (rimso) (1 trial)
diphenhydramine (benadryl) (2 trials)
eflornithine (ornidyl) (1 trial)
egg yolk phospholipids (1 trial)
env (a,b,c,a/e)/gag (c) dna vaccine (1 trial)
ex vivo cd3/cd28 costimulated umbilical cord blood t cells (1 trial)
ex vivo cd3/cd28-costimulated vaccine-primed peripheral blood autologous t cells (1 trial)
ferumoxytol (feraheme) (1 trial)
florbetaben F-18 (neuraceq) (1 trial)
Fluciclovine (Axumin) (1 trial)
fludarabine (fludara) (5 trials)
fluoropropyl-trimethoprim (1 trial)
folate-fluorescein conjugate (6 trials)
ganciclovir (cytovene) (1 trial)
gp-100 peptide vaccine (1 trial)
gp120 (a,b,c,a/e) protein vaccine (1 trial)
htert/survivin multi-peptide vaccine (1 trial)
incomplete freund's adjuvant (1 trial)
lorlatinib (lorbrena) (1 trial)
mesothelin car t cells (5 trials)
mov19-bbz car t cells (1 trial)
nitroglycerin (transderm-nitro) (1 trial)
olanzapine (zyprexa) (1 trial)
pazopanib (votrient) (1 trial)
pek fusion protein vaccine (1 trial)
perfluorooctyl bromide (1 trial)
recombinant adenovirus-hifn-beta (1 trial)
ribociclib (kisqali) (3 trials)
ruboxistaurin mesylate (1 trial)
telomerase: 540-548 peptide vaccine (1 trial)
temsirolimus (torisel) (2 trials)
topotecan (hycamtin) (2 trials)
tositumomab (bexxar) (1 trial)
trabectedin (yondelis) (1 trial)
trastuzumab emtansine (kadcyla) (1 trial)
tumor-pulsed dendritic cells (1 trial)
tumour infiltrating lymphocytes (1 trial)
vaccine-primed cd3/cd28-costimulated autologous t-cells (1 trial)
valaciclovir (Valtrex) (1 trial)
vrc-hivmab080-00-ab (3 trials)
131i-metaiodobenzylguanidine (1 trial)
2-[18f]-fluro-3-[2(s)-2-azethidinylmethoxy]-pyridine (1 trial)
allogeneic blood cells (1 trial)
alteplase (Activase) (1 trial)
ambrisentan (letairis) (1 trial)
amino acids (Freamine) (1 trial)
amphotericin b (fungizone) (1 trial)
bone marrow derived mesenchymal stem cells (1 trial)
branched chain amino acids (1 trial)
calfactant (infasurf) (2 trials)
cannabidiol (Epidiolex) (1 trial)
caspofungin (cancidas) (1 trial)
cetylpyridinium chloride (1 trial)
chromium tripicolinate (1 trial)
decitabine (dacogen) (1 trial)
desipramine (pertofrane) (1 trial)
dinutuximab (unituxin) (1 trial)
dipyridamole (persantine) (1 trial)
estradiol (progynon depot) (2 trials)
gadopenteate dimeglumine (magnevist) (1 trial)
gastric inhibitory polypeptide (1 trial)
hexamethylenetetramine (1 trial)
htert/survivin/cmv multipeptide vaccine (1 trial)
hydroxyethanoic acid (1 trial)
insulin glargine (toujeo) (1 trial)
insulin lispro (humalog) (1 trial)
levothyroxine (Synthroid) (2 trials)
lopinavir (Kaletra) (2 trials)
micafungin (mycamine) (1 trial)
oligofructose-enriched inulin (1 trial)
procaine benzylpenicillin (novocaine) (1 trial)
procarbazine (matulane) (1 trial)
proparacaine (ophthaine) (1 trial)
ranolazine (ranexa) (2 trials)
repaglinide (prandin) (1 trial)
risperidone (risperdal) (1 trial)
sibutramine (meridia) (1 trial)
thalidomide (Thalomid) (1 trial)
Abdominal Injuries (Phase 4)
Abortion, Spontaneous (Phase 3)
Acidosis (Phase 2)
Acne Vulgaris (Phase 4)
Acquired Immunodeficiency Syndrome (Phase 3)
Acute Coronary Syndrome (Phase 2)
Acute Lung Injury (Phase 3)
Acute Pain (Phase 4)
Adamantinoma (Phase 2)
Adenocarcinoma (Phase 4)
Adenocarcinoma, Mucinous (Phase 2)
Adenocarcinoma of Lung (Phase 2)
Adenoma (Phase 2)
Adenoviridae Infections (Phase 2)
Aggression (Phase 3)
AIDS Dementia Complex (Phase 4)
Alcohol Drinking (Phase 4)
Alcoholic Intoxication (Phase 2)
Alcoholism (Phase 4)
Alcohol-Related Disorders (Phase 2)
Alopecia (Phase 2)
Alopecia Areata (Phase 2)
Alzheimer Disease (Phase 3)
Amino Acid Metabolism, Inborn Errors (Phase 2)
Amphetamine-Related Disorders (Phase 3)
Amyloidosis (Phase 4)
Anemia (Phase 4)
Anemia, Hemolytic (Phase 2)
Anemia, Hemolytic, Autoimmune (Phase 2)
Anemia, Sickle Cell (Phase 4)
Anterior Cruciate Ligament Injuries (Phase 3)
Antisocial Personality Disorder (Phase 3)
Anxiety Disorders (Phase 4)
Aortic Arch Syndromes (Phase 2)
Aortic Diseases (Phase 1)
Aortic Valve Stenosis (Phase 2)
Apnea (Phase 3)
Appendiceal Neoplasms (Phase 2)
Arteritis (Phase 3)
Asthma (Phase 4)
Astrocytoma (Phase 1)
Ataxia (Phase 3)
Atherosclerosis (Phase 4)
Atrial Fibrillation (Phase 3)
Atrophy (Phase 2)
Autism Spectrum Disorder (Phase 2)
Autistic Disorder (Phase 2)
Autoimmune Lymphoproliferative Syndrome (Phase 2)
Bacteremia (Phase 4)
Bacterial Infections (Phase 2)
Behavior, Addictive (Phase 3)
beta-Thalassemia (Phase 2)
Binge-Eating Disorder (Phase 3)
Bipolar Disorder (Phase 4)
Birth Weight (Phase 3)
Blindness (Phase 3)
Blood Coagulation Disorders (Phase 2)
Blood Coagulation Disorders, Inherited (Phase 2)
Body Weight (Phase 3)
Brain Concussion (Phase 2)
Brain Diseases (Phase 3)
Brain Injuries (Phase 2)
Brain Injuries, Traumatic (Phase 2)
Brain Ischemia (Phase 3)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 3)
Breast Neoplasms, Male (Phase 2)
Bronchiectasis (Phase 3)
Bronchiolitis (Phase 4)
Bronchiolitis, Viral (Phase 4)
Bronchopulmonary Dysplasia (Phase 3)
Bulimia (Phase 3)
Burkitt Lymphoma (Phase 2)
Calcinosis (Phase 4)
Candidiasis (Phase 4)
Candidiasis, Vulvovaginal (Phase 4)
Carcinoma (Phase 3)
Carcinoma, Ductal (Phase 1)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma in Situ (Phase 1)
Carcinoma, Lobular (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 3)
Carcinoma, Squamous Cell (Phase 3)
Carcinoma, Transitional Cell (Phase 2)
Carcinoma, Verrucous (Phase 2)
Cardiac Complexes, Premature (Phase 3)
Cardiomyopathies (Phase 3)
Cardiomyopathy, Dilated (Phase 2)
Cardiotoxicity (Phase 1)
Cardiovascular Diseases (Phase 4)
Carotid Artery Diseases (Phase 4)
Carotid Body Tumor (Phase 2)
Castleman Disease (Phase 2)
Central Nervous System Neoplasms (Phase 2)
Cerebellar Ataxia (Phase 3)
Cerebral Hemorrhage (Phase 2)
Cervical Intraepithelial Neoplasia (Phase 1)
Cholangiocarcinoma (Phase 2)
Cholangitis (Phase 1)
Cholangitis, Sclerosing (Phase 1)
Choroideremia (Phase 2)
Choroid Plexus Neoplasms (Phase 1)
Chronic Disease (Phase 2)
Chronic Pain (Phase 2)
Churg-Strauss Syndrome (Phase 2)
Clostridium Infections (Phase 2)
Coagulation Protein Disorders (Phase 2)